e-learning
resources
Barcelona 2013
Wednesday, 11.09.2013
Pulmonary circulation: basic science
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
H3K27 histone lysine methylation as potential therapeutic target in pulmonary arterial hypertension
N. Gambaryan, C. Meng, M. Humbert, I. Adcock, S. Wort (London, United Kingdom; Le Plessis-Robinson, France)
Source:
Annual Congress 2013 –Pulmonary circulation: basic science
Session:
Pulmonary circulation: basic science
Session type:
Poster Discussion
Number:
5157
Disease area:
Interstitial lung diseases, Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
N. Gambaryan, C. Meng, M. Humbert, I. Adcock, S. Wort (London, United Kingdom; Le Plessis-Robinson, France). H3K27 histone lysine methylation as potential therapeutic target in pulmonary arterial hypertension. Eur Respir J 2013; 42: Suppl. 57, 5157
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: respiratory care for newborns in resource-limited settings
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Implication of the histone methyltransferase EZH2 in pulmonary arterial hypertension
Source: International Congress 2018 – Pathobiology of pulmonary hypertension
Year: 2018
Epigenome-wide mapping of histone modification landscape in human pulmonary arterial hypertension
Source: ERS Lung Science Conference 2016
Year: 2016
LSC Abstract – Epigenome-wide mapping of histone modification landscape in human pulmonary arterial hypertension
Source: International Congress 2016 – New genomic targets in pulmonary disease
Year: 2016
LSC Abstract – Histone deacetylase 7 mediated metabolic remodeling: A new crosslink between pulmonary hypertension and cancer
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
microRNA-223 suppresses histone deacetylase 2 in chronic obstructive pulmonary disease
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015
Role and regulation of Jumonji C domain-containing histone demethylases 1A and 2B in pulmonary hypertension
Source: International Congress 2016 – The nature of pulmonary hypertension
Year: 2016
Role of class IIa histone deacetylases in the pathogenesis of pulmonary hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Aberrant expression and activity of histone deacetylases in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Translational studies in chronic lung diseases: from bedside to bench
Year: 2013
Prevention of fetal programming of pulmonary vascular dysfunction by a histone deacetylase inhibitor
Source: Annual Congress 2010 - Experimental pulmonary hypertension
Year: 2010
Mutational and epigenetic analysis of the promoter region of
BMPR2
gene in patients with pulmonary arterial hypertension
Source: International Congress 2014 – Pulmonary hypertension: pathobiology
Year: 2014
Epigenetic signature of right ventricular failure in pulmonary arterial hypertension
Source: International Congress 2015 – Pulmonary hypertension: rare and hereditary causes of PAH
Year: 2015
Global histone H3 lysine 4 (H3K4) dimethylation is an important prognostic factor in lung cancer
Source: Annual Congress 2012 - New aspects of lung cancer biology
Year: 2012
The pathophysiological role of novel pulmonary arterial hypertension gene
SOX17
Source: Eur Respir J, 58 (3) 2004172; 10.1183/13993003.04172-2020
Year: 2021
Selective inhibition of BET bromodomain and their effect on nuclear factor-kappa B activation in pulmonary arterial hypertension
Source: Annual Congress 2013 –Pulmonary circulation: basic science
Year: 2013
Histone acetylation and deacetylation: importance in inflammatory lung diseases
Source: Eur Respir J 2005; 25: 552-563
Year: 2005
RASSF1A regulates ROS-HIF axis in hypoxia driven pulmonary hypertension
Source: International Congress 2016 – Pulmonary hypertension: novel insights
Year: 2016
Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target
Source: Eur Respir J 2011; 38: 1453-1460
Year: 2011
LATE-BREAKING ABSTRACT: The bromodomain-containing protein 4: the epigenetic origin of the oncogenic signature in pulmonary hypertension
Source: International Congress 2014 – New technologies and biomarkers in lung disease
Year: 2014
Survivin inhibition as a potential target for pulmonary arterial hypertension
Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept